Neuraxis, INC Contracts & Agreements
83 Contracts & Agreements
- Business Finance (55 contracts)
- Business Operations (2)
- Human Resources (9)
- Intellectual Property (1)
- Uncategorized (16)
- Form of Registration Rights Agreement (Filed With SEC on November 15, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on November 15, 2024)
- Form of Registration Rights Agreement (Filed With SEC on October 18, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on October 18, 2024)
- Fourth Amendment to Securities Purchase Agreement, dated October 12, 2024, between the Company and Flagstaff International, LLC (Filed With SEC on October 18, 2024)
- Second Amendment to the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan (Filed With SEC on August 21, 2024)
- Form of Unrestricted Stock Award Agreement by and between NeurAxis, Inc. and Grantees dated on July 1, 2024 (Filed With SEC on July 5, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on May 28, 2024)
- Form of Convertible Promissory Note (Filed With SEC on May 28, 2024)
- Form of Registration Rights Agreement (Filed With SEC on May 28, 2024)
- Description of the Companys Securities (Filed With SEC on April 16, 2024)
- Form of Convertible Promissory Note issued to Flagstaff International, LLC (Filed With SEC on March 28, 2024)
- Third Amendment to Securities Purchase Agreement, dated March 22, 2024, between the Company and Flagstaff International, LLC (Filed With SEC on March 28, 2024)
- First Amendment to Securities Purchase Agreement, dated February 12, 2024, between the Company and Flagstaff International (Filed With SEC on February 15, 2024)
- Form of Registration Rights Agreement (Filed With SEC on February 15, 2024)
- Form of Convertible Promissory Note (Filed With SEC on February 15, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on February 15, 2024)
- Registration rights agreement, dated November 9, 2023, between the Company and Flagstaff International, LLC (Filed With SEC on November 14, 2023)
- Securities purchase agreement, dated November 9, 2023, between the Company and Flagstaff International, LLC (Filed With SEC on November 14, 2023)
- Underwriting Agreement, dated August 8, 2023, by and between Neuraxis, Inc. and Alexander Capital, L.P (Filed With SEC on August 9, 2023)
- Form of Underwriting Agreement (Filed With SEC on June 29, 2023)
- Form of Registration Rights Agreement related to 2023 Private Placement (Filed With SEC on June 1, 2023)
- Form of Underwriting Agreement (Filed With SEC on June 1, 2023)
- Form of Warrant related to 2023 Private Placement (Filed With SEC on June 1, 2023)
- First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Brian Carrico, dated as of May 4, 2023 (Filed With SEC on June 1, 2023)
- First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Thomas Carrico, dated as of May 4, 2023 (Filed With SEC on June 1, 2023)
- First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Dan Clarence, dated as of May 4, 2023 (Filed With SEC on June 1, 2023)
- First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Christopher Robin Brown, dated as of May 4, 2023 (Filed With SEC on June 1, 2023)
- First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Gary Peterson, dated as of May 4, 2023 (Filed With SEC on June 1, 2023)
- Form of Securities Purchase Agreement related to 2023 Private Placement (Filed With SEC on June 1, 2023)
- Form of Senior Secured Convertible Note related to 2023 Private Placement (Filed With SEC on June 1, 2023)
- Form of Security Agreement related to 2023 Private Placement (Filed With SEC on June 1, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on February 13, 2023)
- Form of Warrant (Filed With SEC on February 13, 2023)
- Form of Underwriting Agreement (Filed With SEC on February 13, 2023)
- First Amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan (Filed With SEC on January 26, 2023)
- Securities Purchase Agreement, dated June 3, 2022, by and between the Neuraxis, Inc. and Leonite Fund I, L.P., Emmis Capital II, LLC, Exchange Listing, LLC, District 2 Capital... (Filed With SEC on January 26, 2023)
- Common Share Purchase Warrant issued to Emmis Capital II, LLC, dated November 30, 2022 (Filed With SEC on January 26, 2023)
- Form of Underwriting Agreement (Filed With SEC on January 26, 2023)
- Quality Agreement between Neuraxis, Inc. and GMI Corporation, dated as of August 24, 2020 (Filed With SEC on January 10, 2023)
- Advisory Agreement, date March 3, 2022, between Exchange Listing, LLC and Neuraxis, Inc., as amended December 22, 2022 (Filed With SEC on January 10, 2023)
- Advisory Agreement, date March 3, 2022, between Exchange Listing, LLC and Neuraxis, Inc (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to District 2 Capital Fund LP, dated October 4, 2022 (Filed With SEC on January 10, 2023)
- License and Collaboration Agreement, dated April 9, 2020, by and between Innovative Health Solutions, Inc. and Masimo Corporation (Filed With SEC on January 10, 2023)
- Second Amendment to Shareholders Agreement, dated January 8, 2023 (Filed With SEC on January 10, 2023)
- Amended and Restated Shareholders Agreement, dated June 13, 2016, and First Amendment to Shareholders Agreement, dated January 30, 2019 (Filed With SEC on January 10, 2023)
- Investor Rights Agreement between Innovative Health Solutions, Inc. and Brian Hannasch, dated September 6, 2019 (Filed With SEC on January 10, 2023)
- Side Letter between NeurAxis, Inc. and Brian P. Hannasch, dated July 7, 2022 (Filed With SEC on January 10, 2023)
- Side Letter between NeurAxis, Inc. and Masimo Corporation, dated December 22, 2022 (Filed With SEC on January 10, 2023)
- Letter Agreement between Innovative Health Solutions, Inc. and Masimo Corporation, dated April 9, 2020 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Bigger Capital Fund, LP, dated October 4, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Bigger Capital Fund, LP, dated August 15, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to District 2 Capital Fund LP, dated November 30, 2022 (Filed With SEC on January 10, 2023)
- Exclusive License Agreement, by and between Innovative Health Solutions, Inc. and TKBMN, LLC (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to District 2 Capital Fund LP, dated August 15, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Exchange Listing, LLC, dated October 4, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Exchange Listing, LLC, dated July 12, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Emmis Capital II, LLC, dated June 10, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Leonite Fund I, LP, dated November 30, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Leonite Fund I, LP, dated October 3, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Leonite Fund I, LP, dated July 8, 2022 (Filed With SEC on January 10, 2023)
- Common Share Purchase Warrant issued to Leonite Fund I, LP, dated June 3, 2022 (Filed With SEC on January 10, 2023)
- Pre-Funded Warrant to Purchase Series A Preferred Stock issued to Masimo Corporation, dated April 9, 2020 (Filed With SEC on January 10, 2023)
- Employment Agreement between Neuraxis, Inc. and Adrian Miranda, dated as of August 17, 2022 (Filed With SEC on January 10, 2023)
- Manufacturing Services Agreement between Neuraxis, Inc. and GMI Corporation, dated as of August 21, 2020 (Filed With SEC on January 10, 2023)
- Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan (Filed With SEC on January 10, 2023)
- Innovative Health Solutions, Inc. 2017 Stock Compensation Plan, as amended (Filed With SEC on January 10, 2023)
- Promissory note of Christopher Robin Brown, dated as of January 1, 2016 (Filed With SEC on January 10, 2023)
- Promissory note of Gary Peterson, dated as of January 1, 2016 (Filed With SEC on January 10, 2023)
- Employment Agreement between Neuraxis, Inc. and Gary Peterson, dated as of August 9, 2022 (Filed With SEC on January 10, 2023)
- Employment Agreement between Neuraxis, Inc. and Christopher Robin Brown, dated as of August 9, 2022 (Filed With SEC on January 10, 2023)
- Employment Agreement between Neuraxis, Inc. and Dan Clarence, dated as of August 9, 2022 (Filed With SEC on January 10, 2023)
- Employment Agreement between Neuraxis, Inc. and Thomas Carrico, dated as of August 9, 2022 (Filed With SEC on January 10, 2023)
- Form of warrant issued to Brian P. Hannasch (Filed With SEC on January 10, 2023)
- Employment Agreement between Neuraxis, Inc. and Brian Carrico, dated as of August 9, 2022 (Filed With SEC on January 10, 2023)
- Pledge and Security Agreement, dated June 3, 2022, between Neuraxis, Inc. and Leonite Fund I, LP (Filed With SEC on January 10, 2023)
- Unsecured Convertible Promissory Note issued to Todd Maxwell, dated December 19, 2022 (Filed With SEC on January 10, 2023)
- Securities Purchase Agreement, dated December 19, 2022, between the Neuraxis, Inc. and Todd Maxwell (Filed With SEC on January 10, 2023)
- Unsecured Convertible Promissory Note issued to Rogan ODonnell, dated December 19, 2022 (Filed With SEC on January 10, 2023)
- Securities Purchase Agreement, dated December 19, 2022, between the Neuraxis, Inc. and Rogan ODonnell (Filed With SEC on January 10, 2023)
- Unsecured Convertible Promissory Note issued to Michele and Michael Robuck, dated December 19, 2022 (Filed With SEC on January 10, 2023)
- Securities Purchase Agreement, dated December 19, 2022, between the Neuraxis, Inc. and Michele and Michael Robuck (Filed With SEC on January 10, 2023)
- Form of Convertible Note related to Exhibits 10.3 (Filed With SEC on January 10, 2023)
